한빛사논문
Dokyun Na 1,†, Do-Hwan Lim 2,3,†, Jae-Sang Hong 2,4, Hyang-Mi Lee 1, Daeahn Cho 1, Myeong-Sang Yu 1, Bilal Shaker 1, Jun Ren 1, Bomi Lee 5, Jae Gwang Song 5, Yuna Oh 6, Kyungeun Lee 6, Kwang-Seok Oh 7, Mi Young Lee 7, Min-Seok Choi 2, Han Saem Choi 5, Yang-Hee Kim 5, Jennifer M Bui 8, Kangseok Lee 9, Hyung Wook Kim 5, Young Sik Lee 2,* & Jörg Gsponer 8,*
1Department of Biomedical Engineering, Chung-Ang University, Seoul, Republic of Korea
2College of Life Sciences and Biotechnology, Korea University, Seoul, Republic of Korea
3School of Systems Biomedical Science, Soongsil University, Seoul, Republic of Korea
4Center for Systems Biology, Massachusetts General Hospital, Boston, MA, USA
5College of Life Sciences, Sejong University, Seoul, Republic of Korea
6Korea Institute of Science and Technology, Seoul, Republic of Korea
7Information-based Drug Research Center, Korea Research Institute of Chemical Technology, Deajeon, Republic of Korea
8Department of Biochemistry and Molecular Biology, Michael Smith Laboratories, University of British Columbia, Vancouver, BC, Canada
9Department of Life Science, Chung-Ang University, Seoul, Republic of Korea
†These authors contributed equally to this work
*Corresponding authors: correspondence to Young Sik Lee or Jörg Gsponer
Abstract
The accumulation of misfolded and aggregated proteins is a hallmark of neurodegenerative proteinopathies. Although multiple genetic loci have been associated with specific neurodegenerative diseases (NDs), molecular mechanisms that may have a broader relevance for most or all proteinopathies remain poorly resolved. In this study, we developed a multi-layered network expansion (MLnet) model to predict protein modifiers that are common to a group of diseases and, therefore, may have broader pathophysiological relevance for that group. When applied to the four NDs Alzheimer's disease (AD), Huntington's disease, and spinocerebellar ataxia types 1 and 3, we predicted multiple members of the insulin pathway, including PDK1, Akt1, InR, and sgg (GSK-3β), as common modifiers. We validated these modifiers with the help of four Drosophila ND models. Further evaluation of Akt1 in human cell-based ND models revealed that activation of Akt1 signaling by the small molecule SC79 increased cell viability in all models. Moreover, treatment of AD model mice with SC79 enhanced their long-term memory and ameliorated dysregulated anxiety levels, which are commonly affected in AD patients. These findings validate MLnet as a valuable tool to uncover molecular pathways and proteins involved in the pathophysiology of entire disease groups and identify potential therapeutic targets that have relevance across disease boundaries. MLnet can be used for any group of diseases and is available as a web tool at http://ssbio.cau.ac.kr/software/mlnet.
논문정보
관련 링크
연구자 키워드
연구자 ID
관련분야 연구자보기
소속기관 논문보기
관련분야 논문보기
해당논문 저자보기